Pure Global

"TERUMO" REDIFOCUS GLIDECATH - Taiwan Registration 98aa5c532e0e7eec127f3b6bd62a1697

Access comprehensive regulatory information for "TERUMO" REDIFOCUS GLIDECATH in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 98aa5c532e0e7eec127f3b6bd62a1697 and manufactured by ASHITAKA FACTORY OF TERUMO CORPORATION. The authorized representative in Taiwan is TERUMO TAIWAN MEDICAL CO., LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
98aa5c532e0e7eec127f3b6bd62a1697
Registration Details
Taiwan FDA Registration: 98aa5c532e0e7eec127f3b6bd62a1697
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

"TERUMO" REDIFOCUS GLIDECATH
TW: ่‘›ไพ†่ก€็ฎกๆ”ๅฝฑๅฐŽ็ฎก
Risk Class 2
MD

Registration Details

98aa5c532e0e7eec127f3b6bd62a1697

Department of Health Medical Device Import No. 008156

DHA00600815605

Company Information

Product Details

0600 Intensive care unit and cardiac intensive monitoring

Produced in Taiwan, China

Dates and Status

Feb 14, 1997

Feb 09, 2029